A brinzolamide (BRN) formulation incorporating two different types of PLGA nanoparticles was injected in the subconjunctival House of normotensive Albino rabbits. The reduction of IOP in both equally BRN-loaded PLGA nanoparticle preparations was higher than topical BRN suspension on your own for nearly 10d[24]. Other subconjunctival nanoparticle de